Quick Order Cart

Cat. No. ARG37961

ARPC1B Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

This product is a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells, featuring targeted disruption of the ARPC1B gene. ARPC1B encodes a subunit of the Arp2/3 complex, which is critical for actin polymerization and branched network formation, regulated by RAC1, CDC42, and the WAVE complex. Knockout of ARPC1B impairs actin-dependent processes such as cell migration and intracellular trafficking, making these cells a valuable model for studying cytoskeletal dynamics, ARPC1B deficiency, and host-pathogen interactions. Typical applications include immunofluorescence, migration assays, and screening for actin modulators. Contact Ascent Research for more details.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ARPC1B

    Gene Identifier

    NCBI Gene ID 10095

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ARPC1B Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the ARPC1B gene in HEK293T cells. This product provides a heterogeneous loss-of-function model for studying ARPC1B-mediated actin dynamics, without clonal isolation, preserving population diversity for robust functional studies.

HEK293T is an adherent human embryonic kidney cell line expressing the SV40 large T antigen, which enhances plasmid amplification and transfection efficiency. Widely employed for protein expression, viral production, and signaling studies, its well-characterized biology and genetic tractability make it an ideal host for cytoskeletal research.

ARPC1B is a critical subunit of the Arp2/3 complex that nucleates branched actin polymerization. It is activated by nucleation-promoting factors such as the WAVE complex (including WASF1, ABI, NCKAP1) and WASp, downstream of RAC1, CDC42, and PIP2. The Arp2/3 complex interacts with other subunits (ARPC2-5, ARP2, ARP3) and regulators like Cortactin and Abi1 to generate branched actin networks driving lamellipodia formation, cell migration, endocytosis, and vesicular trafficking. Disruption of ARPC1B impairs these processes, compromising actin-dependent cellular functions and resulting in defective lamellipodia extension and reduced directional cell migration.

In HEK293T cells, ARPC1B knockout disturbs the intrinsic actin regulatory machinery, offering a platform to dissect Arp2/3-dependent roles in an epithelial cellular context. This model is valuable for investigating the molecular mechanisms underlying ARPC1B deficiency, a disorder marked by autoinflammation, thrombocytopenia, and recurrent infections, and for probing RAC1/CDC42-WAVE-Arp2/3 signaling. Additionally, the knockout cells can be used to study the impact of ARPC1B loss on receptor-mediated endocytosis and intracellular trafficking pathways.

These polyclonal knockout cells are suited for diverse assays: Western blotting of ARPC1B and actin, phalloidin-based F-actin staining, scratch migration assays, immunofluorescence for lamellipodia, co-immunoprecipitation of Arp2/3 complex components, flow cytometry for trafficking-dependent surface receptors, and RT-qPCR for actin remodeling genes. They support research into actin dynamics, host-pathogen interactions, and screening of cytoskeletal modulators. Moreover, they enable functional studies of immune cell-relevant processes such as phagocytosis and migration. For detailed specifications and ordering, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)